logo
ResearchBunny Logo
Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader

Medicine and Health

Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader

A. V. Carmona, S. Jonnalagadda, et al.

Discover the groundbreaking research by Angelica V. Carmona and colleagues on the first-in-class AKR1C3 PROTAC degrader that shows promise in targeting prostate cancer by reducing AKR1C3 expression and degrading ARv7. This innovative approach could change the landscape of prostate cancer treatment.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny